FDA approves Pfizer booster for 16- and 17-year-olds

Lavern Vogel

The U.S. Food and Drug Administration has amended the emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine, authorizing the use of a booster dose for 16-and-17-year olds at the very least 6 months immediately after completion of the main vaccine.

The EUA for a solitary booster dose of the Pfizer vaccine for men and women 16 and 17 a long time of age is centered on the FDA’s past evaluation of immune response data that supported the use of a booster dose in men and women 18 a long time of age and more mature. 

The Food and drug administration analyzed the immune response data from close to two hundred participants 18 through 55 who gained a solitary booster close to 6 months immediately after their next dose. The antibody response against the SARS-CoV-two virus 1 thirty day period immediately after a booster dose of the vaccine, when in comparison to the response 1 thirty day period immediately after the two-dose main sequence in the exact same men and women, demonstrated a booster response.

WHY THIS Matters

Performance of the COVID-19 vaccine has been shown to wane months immediately after the next dose of the main sequence.

As colder temperature brings individuals jointly, the Delta variant, and now the Omicron variant, carry on to travel COVID-19 hospitalizations.

Dr. Peter Marks, director of the FDA’s Heart for Biologics Evaluation and Exploration stated, “Due to the fact we initially approved the vaccine, new proof indicates that vaccine success against COVID-19 is waning immediately after the next dose of the vaccine for all adults and for those in the 16- and 17-year-previous age group.”

THE Greater Craze

On November 19, the Food and drug administration approved the use of a solitary booster dose of the Pfizer vaccine for all men and women 18 and more mature.

Pfizer is currently the only vaccine to acquire Food and drug administration approval as a booster dose for 16- and 17-year-olds. The two-shot main vaccine sequence has been offered for that age group for about a year. 

“The Pfizer-BioNTech COVID-19 Vaccine has been offered to men and women 16 a long time of age and more mature for almost a year, and its rewards have been shown to evidently outweigh potential challenges,” Marks stated by statement.

In August, the Food and drug administration granted Pfizer total vaccine approval.

ON THE Record

“Vaccination and receiving a booster when suitable, along with other preventive actions like masking and staying away from huge crowds and inadequately ventilated areas, continue to be our most helpful approaches for fighting COVID-19,” stated Acting Food and drug administration Commissioner Dr. Janet Woodcock.

“As individuals get indoors with household and buddies for the holiday seasons, we won’t be able to let up on all the preventive public health and fitness actions that we have been getting for the duration of the pandemic. With each the delta and omicron variants continuing to unfold, vaccination stays the best defense against COVID-19.” 

Twitter: @SusanJMorse
Electronic mail the writer: [email protected]  

Next Post


What’s SEO advertising? Startup costs are fairly high, as a considerable amount of indoor area is required, together with things like gear and insurance. Because of the high maintenance costs and decrease rates charged to clients, incomes potential is just not as high as a number of the different companies […]